WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticonvulsant Efficacy Endpoints - v2 (Mike reorg), Efficacy endpoints assessed by Potential exacerbation of pre-existing seizures, Patients suffer from Infantile spasms (IS), Median % change of total seizures assessed during Maintenance phase, Closed Circuit Television Electroencephalography (CCTV-EEG) monitoring monitored following Spasm freedom, Minimal improvement is quantified by Proportion of patients, Avg daily spasm freq quantified by % change, Efficacy endpoints include Seizure severity, Complex partial seizures (CPS) classified as Type 1B, Closed Circuit Television Electroencephalography (CCTV-EEG) monitoring observes Hypsarrythmia, Last spasm date reported by Caregiver, Spasm freedom occuring over Defined timepoints, Diary classified by Investigator, Potiga a.k.a Ezogabine, Closed Circuit Television Electroencephalography (CCTV-EEG) monitoring recorded for Defined timepoints, % change in total partial seizure freq is assessed between Baseline, Partial secondarily generalized seizures classified as Type 1C, Patients can experience Motor function abnormalities, Distribution of change in seizure frequency assessed over Quartiles, Efficacy endpoints include Physician global assessment, Defined timepoints include 3 mo